2.3.1.203	drug development	development of a new series of thienopyrimidine-6-carboxylate inhibitors of the Campylobacter jejuni PglD UDP-amino-sugar acetyltransferase enzyme, which upon further optimization may lead to new agents with targeted antivirulence activity	-, 757388